Neural Representations of Memory Transformation (MEM_TRANS)

NCT ID: NCT06862622

Last Updated: 2026-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-03-01

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigators overarching goal is to provide evidence for the link between altered spatiotemporal (where and when) neural mechanisms and the extent of changed memory maintenance in healthy older adults and to identify potential neural markers of compensatory function (cognitive resource). Investigators preliminary studies suggest that healthy older adults, compared to younger adults, benefit behaviorally from increased coupling between frontal and parietal brain waves when retrieving and updating well-consolidated visuomotor sequence memory via stronger top-down cognitive control of memory maintenance. Thus, Investigators central hypothesis is that the dynamics across cortical and subcortical regions (i.e., spatiotemporal representations) during transitions between different levels of memory stability indicate the efficiency of memory maintenance. The rationale is that while temporal and spatial neural signatures carry distinct mechanistic information, the joint definition of spatial and temporal representations will allow the differentiation of compensatory versus neurodegenerative mechanisms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To investigate the spatiotemporal neural dynamics during memory maintenance mechanisms, healthy older adults will practice a computer-based online visuomotor sequence learning task over consecutive days until reaching a performance plateau. At the performance plateau, participants will undergo concurrent electroencephalography and magnetic resonance imaging (EEG-fMRI) while being exposed to a behavioral interference intervention to perturb the stability of the previously stored memory trace to extract spatiotemporal neural dynamics during these transitional states. Additionally, participants will undergo an additional brain scan to quantify aging-related neurodegeneration based on grey- and white-matter integrity, cerebral perfusion, and resting-state connectivity. Cognitive functioning and putative confounders of learning and memory will be quantified with standardized assessments. The experimental procedures include an individual number of daily computer-based sessions of task practice at home, and two lab visits including questionnaires, neuropsychological testing, and two MRI brain scans distributed over approximately two weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Older Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

behavioral skill learning intervention

All participants in this study undergo daily practice of a new skill until change through practice stabilizes (plateau).

Computer-based visuomotor sequence learning and interference

Intervention Type BEHAVIORAL

The behavioral sequence learning and interference paradigm allows the experimental manipulation of sequence memory after long-term consolidation achieved through individualized longitudinal practice and serves the extraction of the primary behavioral outcome. The learning task requires participants to respond with keypresses on a standard computer keyboard of visual targets. Participants will implicitly (without being made aware) learn sequential regularities provided through the recurring order of cued keys contrasted with random keys. Participants will practice the learning task remotely over consecutive days until a stable performance plateau is reached. During this phase, data will be collected online, and behavioral change will be monitored in real time. Then participants will undergo the behavioral interference intervention, in which the initially learned sequence memory will be perturbed through (implicit) exposure to new sequential information (i.e., interference).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Computer-based visuomotor sequence learning and interference

The behavioral sequence learning and interference paradigm allows the experimental manipulation of sequence memory after long-term consolidation achieved through individualized longitudinal practice and serves the extraction of the primary behavioral outcome. The learning task requires participants to respond with keypresses on a standard computer keyboard of visual targets. Participants will implicitly (without being made aware) learn sequential regularities provided through the recurring order of cued keys contrasted with random keys. Participants will practice the learning task remotely over consecutive days until a stable performance plateau is reached. During this phase, data will be collected online, and behavioral change will be monitored in real time. Then participants will undergo the behavioral interference intervention, in which the initially learned sequence memory will be perturbed through (implicit) exposure to new sequential information (i.e., interference).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or older (80 of the final sample will be ≥60years of age)
* Cognitively unimpaired, ambiguous, or mildly impaired cognitive function, defined as a score of ≥18 in the Montreal Cognitive Assessment (MOCA).
* No previous stroke, brain tumor, neurodegenerative disease, or trauma to the head
* Ability to give consent for study participation
* Ability to perform a computer task requiring responding to visual cues and typing on a standard computer keyboard with both index and middle fingers for 30 minutes daily.

Exclusion Criteria

* Inability to use both index and middle fingers to type on a standard computer keyboard
* Dementia defined as a score of \<18 in the Montreal Cognitive Assessment (MOCA)
* Uncorrected vision, hindering perception of visual cues presented on a standard computer screen
* Medication use at the time of study that may interfere with learning, including but not limited to carbamazepine, flunarizine, sulpiride, rivastigmine, and dextromethorphan.
* Neuromuscular disorders that affect fine motor control of the hands.
* Presence of neurological or psychiatric disorders
* Presence of scalp injury or disease
* Prior intracranial surgery
* Prior brain radiotherapy
* Prior history of intracranial tumor, intracranial infection, or cerebrovascular malformation
* Metal in the head or neck
* Contraindications to MRI (such as severe claustrophobia, implanted medical devices)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

Medical University of South Carolina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kirstin-Friederike Heise

Assistant Professor-Faculty

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kirstin-Friederike Heise, PhD

Role: PRINCIPAL_INVESTIGATOR

Medical University of South Carolina

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Principal Investigator

Role: CONTACT

(843)792-3435

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00141769

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brain Encoding for Memory
NCT00051870 COMPLETED
Basic Experimental Study of Hippocampal Memory Functions
NCT05945628 ENROLLING_BY_INVITATION NA
Reliability of the Human Brain Connectome
NCT02193425 COMPLETED EARLY_PHASE1